IRIS - Res&Arch Institutional Research Information System - Research & Archive

PARNETTI, Lucilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.514
AS - Asia 10.656
EU - Europa 9.828
SA - Sud America 2.010
AF - Africa 279
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 14
Totale 37.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.160
SG - Singapore 4.969
IE - Irlanda 1.747
BR - Brasile 1.577
IT - Italia 1.437
UA - Ucraina 1.434
CN - Cina 1.424
RU - Federazione Russa 1.410
HK - Hong Kong 1.344
VN - Vietnam 1.131
DE - Germania 770
SE - Svezia 753
FR - Francia 652
FI - Finlandia 529
KR - Corea 363
GB - Regno Unito 334
BD - Bangladesh 266
IN - India 232
CA - Canada 180
TR - Turchia 163
AR - Argentina 152
IQ - Iraq 126
AT - Austria 103
NL - Olanda 103
PL - Polonia 103
MX - Messico 93
JP - Giappone 90
RO - Romania 87
ZA - Sudafrica 73
UZ - Uzbekistan 72
PK - Pakistan 68
ID - Indonesia 66
CH - Svizzera 65
CO - Colombia 60
VE - Venezuela 59
SA - Arabia Saudita 55
ES - Italia 54
EC - Ecuador 52
CZ - Repubblica Ceca 49
BE - Belgio 48
CL - Cile 36
MA - Marocco 31
EG - Egitto 29
PH - Filippine 28
JO - Giordania 27
PY - Paraguay 26
GR - Grecia 25
DZ - Algeria 24
KE - Kenya 24
TN - Tunisia 24
AE - Emirati Arabi Uniti 23
LB - Libano 23
LT - Lituania 23
MY - Malesia 20
NP - Nepal 18
PE - Perù 18
AZ - Azerbaigian 15
JM - Giamaica 15
ET - Etiopia 14
KZ - Kazakistan 14
AL - Albania 13
AU - Australia 13
BO - Bolivia 13
CR - Costa Rica 13
DK - Danimarca 13
IL - Israele 13
UY - Uruguay 13
NZ - Nuova Zelanda 12
OM - Oman 12
EU - Europa 11
HR - Croazia 10
IR - Iran 10
PT - Portogallo 10
AM - Armenia 9
BG - Bulgaria 9
KG - Kirghizistan 9
NI - Nicaragua 8
PA - Panama 8
TH - Thailandia 8
AO - Angola 7
PS - Palestinian Territory 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
DO - Repubblica Dominicana 6
MD - Moldavia 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BY - Bielorussia 5
GE - Georgia 5
RS - Serbia 5
SI - Slovenia 5
BH - Bahrain 4
CG - Congo 4
CI - Costa d'Avorio 4
GT - Guatemala 4
HN - Honduras 4
LV - Lettonia 4
LY - Libia 4
QA - Qatar 4
Totale 37.227
Salva come PNG Salva come JPEG
Città #
Singapore 3.549
Chandler 1.968
Dublin 1.745
San Jose 1.335
Hong Kong 1.330
Ashburn 871
San Mateo 851
Jacksonville 748
Boardman 682
Santa Clara 540
Moscow 521
Dong Ket 479
Altamura 474
Medford 408
Princeton 402
Lauterbourg 396
Perugia 361
Wilmington 358
Seoul 356
Lawrence 355
Beijing 335
Los Angeles 268
Ann Arbor 259
Des Moines 253
Munich 228
The Dalles 211
Ho Chi Minh City 209
New York 192
Andover 184
Hanoi 158
Piscataway 144
São Paulo 132
Helsinki 131
Saint Petersburg 121
Falls Church 94
San Paolo di Civitate 94
Turku 93
Frankfurt am Main 89
Orem 84
Tokyo 83
Norwalk 73
Brooklyn 71
Montreal 68
Woodbridge 67
Izmir 66
Warsaw 66
Nuremberg 65
Chennai 64
Denver 63
Baghdad 58
Dallas 58
Houston 54
Redmond 54
Columbus 52
Rome 51
Amsterdam 49
Chicago 49
London 48
Stockholm 48
Belo Horizonte 46
Atlanta 44
Tashkent 43
Brussels 42
Shanghai 42
Poplar 41
Boston 40
Johannesburg 40
Toronto 39
Manchester 38
Phoenix 38
Rio de Janeiro 38
Bucharest 36
Timisoara 35
Council Bluffs 33
Milan 33
Vienna 32
Curitiba 31
Brasília 29
Da Nang 29
Haiphong 27
Mexico City 27
Redwood City 27
San Francisco 27
Campinas 26
Amman 24
Istanbul 24
Naples 24
Seattle 24
Caracas 23
Charlotte 23
Guangzhou 23
Lahore 22
Riyadh 22
Hefei 21
Lappeenranta 21
Den Haag 20
Dhaka 20
Nairobi 20
New Delhi 20
Fortaleza 19
Totale 23.448
Salva come PNG Salva come JPEG
Nome #
CSF and blood biomarkers for Parkinson's disease 202
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults 186
A new assay for antiphospholipid antibodies in patient with ischemic stroke 166
Apopoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer’s disease and vascular dementia patients 166
a-D-Mannosidses in patients with familial Alzheimer's Disease 154
102.Evolutionary trends in carotid atherosclerotic plaques: results of a two-year follow-up study using an ultrasound imaging system. 153
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 150
Platelet MAO-B activity and vitamin B12 in old age dementias. 147
First-ever stroke and outcome in patients admitted to Perugia Stroke Unit:predictors for death, dependency, and recurrence of stroke within the first three months. 146
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 145
a-D-Mannosidases in patients with Alzheimer's disease 141
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 133
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 133
Brain SPECT in pathological aging brain: Alzheimer's disease, mild cognitive impairment and age-associated cognitive impairment. 132
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. 132
Hippocampal epileptogenesis in autoimmune encephalitis 132
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 131
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 131
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 128
Blood pressure and functional aspects of the aging brain. 127
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 127
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 126
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 126
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 126
1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. 125
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. 125
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 125
A magnetization transfer study of mild and advanced Parkinson's disease. 125
Swalloving dysfunction: neurovascolar- anatomical correlation. 124
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 124
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 123
99mTc-HMPAO-SPECT nell'invecchiamento cerebrale fisiologico, nei deficit di memoria età correlati e nella malattia di Alzheimer: studio longitudinale a un anno. 122
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. 122
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 122
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study 122
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies 121
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 121
Cerebrospinal fluid biomarkers in Parkinson disease. 121
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 121
Acetylcholinesterase and butyrylcholinesterase activity in cerebrospinal fluid of Alzheimer patients before and after 6-months treatment with donepezil. XXXI Congresso Società Italiana di Neurologia 120
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 120
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 119
99mTc-HMPAO cerebral SPECT in cerebrovascular disease with and without dementia. 119
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 119
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 119
Early admission to stroke unit influences clinical outcome 118
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 118
Brain SPECT in pathological aging brain: Alzheimer’s disease, mild cognitive impairment and age-associated cognitive impairment 117
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 117
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 117
A combination of CSF Tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. 116
B-mode imaging and histomorphometric evaluation of carotid atherosclerosis. 116
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 115
99mTc-HMPAO-SPECT contribution in the differential diagnosis of cognitive dysfunction. 114
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 114
Stroke related to carotid artery dissection in a young patient with Takayasu arteritis, systemic lupus erythematosus and antiphospholipid antibody syndrome. 113
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 113
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. 112
[Drinking-water and cardiovascular mortality]. 112
Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. 112
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 112
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia 111
Cannabidiol: metabolism and clinical efficacy in epileptic patients 110
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 110
Expression of d-mannosidase in amyotrophic lateral sclerosis and Alzheimer's disease 110
Is multi-infarct dementia representative of vascular dementias? A retrospective study 110
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillation. 110
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 110
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 110
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 110
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 109
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 109
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 109
Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s Disease 109
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 109
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 107
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly 107
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 107
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 107
Risk factors and stroke subtypes: results of five consecutive years of the Perugia Stroke Registry 106
Brain SPECT in the diagnosis of degenerative dementia. 106
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 106
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group. 106
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 106
Amyloid-β: a potential link between epilepsy and cognitive decline 106
Variazioni di attività della paraoxonasi serica nella fase acuta dello stroke ischemico. Stroke'99 Meeting on Cerebrovascular Diseases 105
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. 105
[Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases]. 105
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 105
Lysosomal enzyme activities in human brain 104
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 104
Association between migraine and headache attributed to stroke: a case-control study. 103
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 103
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 103
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 103
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type. 103
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study 103
Cerebrospinal fluid biomarkers and white matter lesions: can we know more? 102
Atrial fibrillation and stroke. 102
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 102
Totale 11.987
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.033
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021538 0 0 0 0 0 0 0 0 0 0 0 538
2021/20223.192 80 580 88 141 96 85 53 944 100 131 372 522
2022/20236.532 437 1.297 81 564 491 799 15 271 2.295 18 197 67
2023/20242.424 184 280 126 59 27 14 463 97 273 99 397 405
2024/20256.102 86 606 234 283 761 351 191 456 1.231 417 995 491
2025/202614.196 1.032 1.005 782 1.935 1.889 1.263 2.360 717 1.440 1.119 445 209
Totale 38.202